{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:50:25Z","timestamp":1781200225505,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s10067-022-06251-7","type":"journal-article","created":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T23:02:38Z","timestamp":1655938958000},"page":"2977-2986","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Predictors of hospitalization in patients with systemic lupus erythematosus: a 10-year cohort study"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8849-3828","authenticated-orcid":false,"given":"Helena","family":"Assun\u00e7\u00e3o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00edlia","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Rita","family":"Prata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Lu\u00eds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A. P.","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds","family":"In\u00eas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,23]]},"reference":[{"issue":"11","key":"6251_CR1","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.3899\/jrheum.080214","volume":"35","author":"MB Urowitz","year":"2008","unstructured":"Urowitz MB, Gladman DD, Tom BD, Iba\u00f1ez D, Farewell VT (2008) Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. J Rheumatol 35(11):2152\u20132158. https:\/\/doi.org\/10.3899\/jrheum.080214","journal-title":"J Rheumatol"},{"issue":"Suppl5","key":"6251_CR2","doi-asserted-by":"publisher","first-page":"v29","DOI":"10.1093\/rheumatology\/keaa382","volume":"59","author":"L Arnaud","year":"2020","unstructured":"Arnaud L, Tektonidou MG (2020) Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors. Rheumatology (Oxford) 59(Suppl5):v29\u2013v38. https:\/\/doi.org\/10.1093\/rheumatology\/keaa382","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"6251_CR3","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1177\/0961203321990086","volume":"30","author":"R Aldarmaki","year":"2021","unstructured":"Aldarmaki R, Al Khogali HI, Al Dhanhani AM (2021) Hospitalization in patients with systemic lupus erythematosus at Tawam Hospital, United Arab Emirates (UAE): rates, causes, and factors associated with length of stay. Lupus 30(5):845\u2013851. https:\/\/doi.org\/10.1177\/0961203321990086","journal-title":"Lupus"},{"issue":"9","key":"6251_CR4","first-page":"1770","volume":"33","author":"E Krishnan","year":"2006","unstructured":"Krishnan E (2006) Hospitalization and mortality of patients with systemic lupus erythematosus. J Rheumatol 33(9):1770\u20131774","journal-title":"J Rheumatol"},{"issue":"10","key":"6251_CR5","first-page":"1559","volume":"19","author":"M Petri","year":"1992","unstructured":"Petri M, Genovese M (1992) Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins Lupus Cohort. J Rheumatol 19(10):1559\u20131565","journal-title":"J Rheumatol"},{"issue":"9","key":"6251_CR6","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1191\/0961203303lu452oa","volume":"12","author":"CJ Edwards","year":"2003","unstructured":"Edwards CJ, Lian TY, Badsha H, Teh CL, Arden N, Chng HH (2003) Hospitalization of individuals with systemic lupus erythematosus: characteristics and predictors of outcome. Lupus 12(9):672\u2013676. https:\/\/doi.org\/10.1191\/0961203303lu452oa","journal-title":"Lupus"},{"issue":"4","key":"6251_CR7","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/art.41144","volume":"72","author":"A Legge","year":"2020","unstructured":"Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C et al (2020) Prediction of hospitalizations in systemic lupus erythematosus using the Systemic Lupus International Collaborating Clinics Frailty Index (SLICC-FI). Arthritis Rheumatol Hoboken, N.J. 72(4):658\u2013666. https:\/\/doi.org\/10.1002\/art.41144","journal-title":"Arthritis Rheumatol Hoboken, N.J."},{"issue":"1","key":"6251_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1177\/0961203317734919","volume":"27","author":"RW Busch","year":"2018","unstructured":"Busch RW, Kay SD, Voss A (2018) Hospitalizations among Danish SLE patients: a prospective study on incidence, causes of admission and risk factors in a population-based cohort. Lupus 27(1):165\u2013171. https:\/\/doi.org\/10.1177\/0961203317734919","journal-title":"Lupus"},{"issue":"8","key":"6251_CR9","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1177\/0961203318770534","volume":"27","author":"D Li","year":"2018","unstructured":"Li D, Madhoun HM, Roberts WN Jr, Jarjour W (2018) Determining risk factors that increase hospitalizations in patients with systemic lupus erythematosus. Lupus 27(8):1321\u20131328. https:\/\/doi.org\/10.1177\/0961203318770534","journal-title":"Lupus"},{"issue":"7","key":"6251_CR10","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1177\/0961203316676641","volume":"26","author":"AP Anandarajah","year":"2017","unstructured":"Anandarajah AP, Luc M, Ritchlin CT (2017) Hospitalization of patients with systemic lupus erythematosus is a major cause of direct and indirect healthcare costs. Lupus 26(7):756\u2013761. https:\/\/doi.org\/10.1177\/0961203316676641","journal-title":"Lupus"},{"issue":"9","key":"6251_CR11","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/acr.20502","volume":"63","author":"KA Slawsky","year":"2011","unstructured":"Slawsky KA, Fernandes AW, Fusfeld L, Manzi S, Goss TF (2011) A structured literature review of the direct costs of adult systemic lupus erythematosus in the US. Arthritis Care Res (Hoboken) 63(9):1224\u20131232. https:\/\/doi.org\/10.1002\/acr.20502","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"6251_CR12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1177\/0961203312465780","volume":"22","author":"CL Teh","year":"2013","unstructured":"Teh CL, Ling GR (2013) Causes and predictors of mortality in hospitalized lupus patient in Sarawak General Hospital, Malaysia. Lupus 22(1):106\u2013111. https:\/\/doi.org\/10.1177\/0961203312465780","journal-title":"Lupus"},{"issue":"5","key":"6251_CR13","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/rheumatology\/kes391","volume":"52","author":"J Lee","year":"2013","unstructured":"Lee J, Dhillon N, Pope J (2013) All-cause hospitalizations in systemic lupus erythematosus from a large Canadian referral centre. Rheumatology (Oxford) 52(5):905\u2013909. https:\/\/doi.org\/10.1093\/rheumatology\/kes391","journal-title":"Rheumatology (Oxford)"},{"issue":"13","key":"6251_CR14","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1177\/0961203316640916","volume":"25","author":"JW Lee","year":"2016","unstructured":"Lee JW, Park DJ, Kang JH, Choi SE, Yim YR, Kim JE et al (2016) The rate of and risk factors for frequent hospitalization in systemic lupus erythematosus: results from the Korean lupus network registry. Lupus 25(13):1412\u20131419. https:\/\/doi.org\/10.1177\/0961203316640916","journal-title":"Lupus"},{"issue":"8","key":"6251_CR15","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3899\/jrheum.170072","volume":"44","author":"K Gu","year":"2017","unstructured":"Gu K, Gladman DD, Su J, Urowitz MB (2017) Hospitalizations in patients with systemic lupus erythematosus in an academic health science center. J Rheumatol 44(8):1173\u20131178. https:\/\/doi.org\/10.3899\/jrheum.170072","journal-title":"J Rheumatol"},{"issue":"9","key":"6251_CR16","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1177\/0961203319861685","volume":"28","author":"GPD Rosa","year":"2019","unstructured":"Rosa GPD, Ortega MF, Teixeira A, Espinosa G, Cervera R (2019) Causes and factors related to hospitalizations in patients with systemic lupus erythematosus: analysis of a 20-year period (1995\u20132015) from a single referral centre in Catalonia. Lupus 28(9):1158\u20131166. https:\/\/doi.org\/10.1177\/0961203319861685","journal-title":"Lupus"},{"issue":"10","key":"6251_CR17","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/s00296-018-4147-5","volume":"38","author":"O Levy","year":"2018","unstructured":"Levy O, Markov A, Drob Y, Maslakov I, Tishler M, Amit-Vazina M (2018) All-cause hospitalizations in systemic lupus erythematosus from a single medical center in Israel. Rheumatol Int 38(10):1841\u20131846. https:\/\/doi.org\/10.1007\/s00296-018-4147-5","journal-title":"Rheumatol Int"},{"issue":"6","key":"6251_CR18","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1002\/art.22641","volume":"56","author":"EF Chakravarty","year":"2007","unstructured":"Chakravarty EF, Bush TM, Manzi S, Clarke AE, Ward MM (2007) Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheum 56(6):2092\u20132094. https:\/\/doi.org\/10.1002\/art.22641","journal-title":"Arthritis Rheum"},{"issue":"13","key":"6251_CR19","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1177\/0961203313505689","volume":"22","author":"J Lee","year":"2013","unstructured":"Lee J, Peschken CA, Muangchan C, Silverman E, Pineau C, Smith CD et al (2013) The frequency of and associations with hospitalization secondary to lupus flares from the 1000 Faces of Lupus Canadian cohort. Lupus 22(13):1341\u20131348. https:\/\/doi.org\/10.1177\/0961203313505689","journal-title":"Lupus"},{"issue":"3","key":"6251_CR20","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/annrheumdis-2018-214502","volume":"78","author":"D Jesus","year":"2019","unstructured":"Jesus D, Matos A, Henriques C, Zen M, Larosa M, Iaccarino L et al (2019) Derivation and validation of the SLE Disease Activity Score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity. Ann Rheum Dis 78(3):365\u2013371. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214502","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"6251_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/rheumatology\/ket322","volume":"53","author":"L In\u00eas","year":"2014","unstructured":"In\u00eas L, Duarte C, Silva RS, Teixeira AS, Fonseca FP, da Silva JA (2014) Identification of clinical predictors of flare in systemic lupus erythematosus patients: a 24-month prospective cohort study. Rheumatology (Oxford) 53(1):85\u201389. https:\/\/doi.org\/10.1093\/rheumatology\/ket322","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"6251_CR22","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1177\/0961203317731534","volume":"27","author":"L In\u00eas","year":"2018","unstructured":"In\u00eas L, Rodrigues M, Jesus D, Fonseca FP, Silva JAP (2018) Risk of damage and mortality in SLE patients fulfilling the ACR or only the SLICC classification criteria. A 10-year, inception cohort study. Lupus 27(4):556\u2013563. https:\/\/doi.org\/10.1177\/0961203317731534","journal-title":"Lupus"},{"issue":"9","key":"6251_CR23","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725. https:\/\/doi.org\/10.1002\/art.1780400928","journal-title":"Arthritis Rheum"},{"issue":"8","key":"6251_CR24","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai AM, Alarc\u00f3n GS, Gordon C, Merril JT, Fortin PR et al (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64(8):2677\u20132686. https:\/\/doi.org\/10.1002\/art.34473","journal-title":"Arthritis Rheum"},{"issue":"2","key":"6251_CR25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4(2):295\u2013306. https:\/\/doi.org\/10.1111\/j.1538-7836.2006.01753.x","journal-title":"J Thromb Haemost"},{"issue":"2","key":"6251_CR26","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman DD, Iba\u00f1ez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29(2):288\u2013291","journal-title":"J Rheumatol"},{"issue":"8","key":"6251_CR27","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1191\/096120399680411335","volume":"8","author":"DD Gladman","year":"1999","unstructured":"Gladman DD, Urowitz MB (1999) The SLICC\/ACR damage index: progress report and experience in the field. Lupus 8(8):632\u2013637. https:\/\/doi.org\/10.1191\/096120399680411335","journal-title":"Lupus"},{"key":"6251_CR28","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","volume":"78","author":"A Fanouriakis","year":"2019","unstructured":"Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis J et al (2019) 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis 78:736\u2013745. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215089","journal-title":"Ann Rheum Dis"},{"issue":"suppl_1","key":"6251_CR29","doi-asserted-by":"publisher","first-page":"i67","DOI":"10.1093\/rheumatology\/kew399","volume":"56","author":"MJ Lewis","year":"2017","unstructured":"Lewis MJ, Jawad AS (2017) The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus. Rheumatology (Oxford) 56(suppl_1):i67\u2013i77. https:\/\/doi.org\/10.1093\/rheumatology\/kew399","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"6251_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1001\/archinte.164.1.77","volume":"164","author":"G Ruiz-Irastorza","year":"2004","unstructured":"Ruiz-Irastorza G, Egurbide MV, Ugalde J, Aguirre C (2004) High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus. Arch Intern Med 164(1):77\u201382. https:\/\/doi.org\/10.1001\/archinte.164.1.77","journal-title":"Arch Intern Med"},{"issue":"12","key":"6251_CR31","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1177\/0961203320950477","volume":"29","author":"L Riancho-Zarrabeitia","year":"2020","unstructured":"Riancho-Zarrabeitia L, Mart\u00ednez-Taboada V, R\u00faa-Figueroa I, Alonso F, Galindo-Izquierdo M, Ovalles J et al (2020) Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality. Lupus 29(12):1556\u20131565. https:\/\/doi.org\/10.1177\/0961203320950477","journal-title":"Lupus"},{"issue":"9","key":"6251_CR32","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1177\/0961203314531839","volume":"23","author":"M De\u00e1k","year":"2014","unstructured":"De\u00e1k M, Bocskai M, Burcs\u00e1r S, D\u00e1nyi O, Fekete Z, Kov\u00e1cs L (2014) Non-thromboembolic risk in systemic lupus erythematosus associated with antiphospholipid syndrome. Lupus 23(9):913\u2013918. https:\/\/doi.org\/10.1177\/0961203314531839","journal-title":"Lupus"},{"issue":"4","key":"6251_CR33","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1177\/0961203317734924","volume":"27","author":"U \u0130lgen","year":"2018","unstructured":"\u0130lgen U, Yayla ME, Ate\u015f A, Okatan IE, Yurteri EU, Torgutalp M et al (2018) Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus. Lupus 27(4):665\u2013669. https:\/\/doi.org\/10.1177\/0961203317734924","journal-title":"Lupus"},{"key":"6251_CR34","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1136\/annrheumdis-2013-205171","volume":"74","author":"IN Bruce","year":"2015","unstructured":"Bruce IN, O\u2019Keeffe AG, Farewell V, Hanly JG, Manzi S, Li Su et al (2015) Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort. Ann Rheum Dis 74:1706\u20131713. https:\/\/doi.org\/10.1136\/annrheumdis-2013-205171","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"6251_CR35","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1136\/ard.2006.068676","volume":"66","author":"GS Alarc\u00f3n","year":"2007","unstructured":"Alarc\u00f3n GS, McGwin G, Bertoli AM, Fessler BJ, Calvo-Al\u00e9n J, Bastian HM et al (2007) Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L). Ann Rheum Dis 66(9):1168\u20131172. https:\/\/doi.org\/10.1136\/ard.2006.068676","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"6251_CR36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1136\/ard.2008.101766","volume":"69","author":"G Ruiz-Irastorza","year":"2010","unstructured":"Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA (2010) Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis 69(1):20\u201328. https:\/\/doi.org\/10.1136\/ard.2008.101766","journal-title":"Ann Rheum Dis"},{"key":"6251_CR37","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.2147\/DDDT.S166893","volume":"12","author":"D Liu","year":"2018","unstructured":"Liu D, Li X, Zhang Y, Kwong JSW, Li L, Zhang Y et al (2018) Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis. Drug Des Devel Ther 12:1685\u20131695. https:\/\/doi.org\/10.2147\/DDDT.S166893","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"6251_CR38","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.semarthrit.2017.01.010","volume":"47","author":"\u00cd R\u00faa-Figueroa","year":"2017","unstructured":"R\u00faa-Figueroa \u00cd, L\u00f3pez-Longo J, Galindo-Izquierdo M, Calvo-Al\u00e9n J, Del Campo V, Oliv\u00e9-Marqu\u00e9s A et al (2017) Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus. Semin Arthritis Rheum 47(1):38\u201345. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.01.010","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"6251_CR39","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s10067-021-05988-x","volume":"41","author":"AR Prata","year":"2021","unstructured":"Prata AR, Lu\u00eds M, Assun\u00e7\u00e3o H, da Silva JAP, In\u00eas LS (2021) Antimalarial treatment and minimizing prednisolone are associated with lower risk of infection in SLE: a 24-month prospective cohort study. Clin Rheumatol 41(4):1069\u20131078. https:\/\/doi.org\/10.1007\/s10067-021-05988-x","journal-title":"Clin Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06251-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06251-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06251-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T14:28:38Z","timestamp":1663597718000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06251-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,23]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["6251"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06251-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,23]]},"assertion":[{"value":"13 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This project was conducted according to the principles of the Declaration of Helsinki and was approved by the Ethics Committee of Centro Hospitalar e Universit\u00e1rio de Coimbra (protocol number CHUC04618). All patients signed an informed consent form before the inclusion in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}